NR2E3 and retinitis pigmentosa 1: Expression of nuclear receptor Nr2e3 via AAV8-Nr2e3 gene therapy in multiple unique mouse models of retinitis pigmentosa (RP) and Leber Congenital Amaurosis (LCA) resulted in restoration of photoreceptor cells and improved retinal function [95].